Sponsor or institution
Clinical trials and research at Tau-MEDICAL Co., Ltd.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Tau-MEDICAL Co., Ltd. that are recruiting, at sites in 3 countries (most in Australia (2), South Korea (1), Georgia (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pivot Bridge device for massive functional tricuspid regurgitation: safety and effectiveness | — | Daegu, Dalseo-gu and 3 other locations | Recruiting | Feb 4, 2026 |
| Pivot Extend device to treat severe tricuspid regurgitation | — | Macquarie Park, New South Wales | Recruiting | Sep 15, 2025 |
| Early feasibility test of the CAROL device for treating small (≤2 cm) stage 1 NSCLC lung tumors | — | Melbourne, Victoria | Recruiting | Aug 14, 2025 |
| Treatment for severe tricuspid regurgitation using the Pivot Extend device | — | Tbilisi, K'alak'i T'bilisi and 2 other locations | Recruiting | Mar 14, 2025 |
All recruiting trials (4)
-
Pivot Bridge device for massive functional tricuspid regurgitation: safety and effectiveness
This trial will test whether the Pivot Bridge spacer is safe and improves symptoms in adults with massive functional tricuspid regurgitation who have already been on medical therapy for at least one month.
-
Pivot Extend device to treat severe tricuspid regurgitation
This trial will try the Pivot Extend device in adults with severe, symptomatic tricuspid regurgitation to see if it safely reduces valve leakage and improves symptoms.
-
Early feasibility test of the CAROL device for treating small (≤2 cm) stage 1 NSCLC lung tumors
This study will test the CAROL device in adults with stage 1 non-small cell lung cancer (tumors ≤2 cm) to see if the treatment can be used safely.
-
Treatment for severe tricuspid regurgitation using the Pivot Extend device
This study is testing a new device to see if it can help people with severe tricuspid regurgitation who haven't improved with regular treatments.
Quick answers
How many clinical trials run by Tau-MEDICAL Co., Ltd. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Australia (2 trials), South Korea (1 trial), Georgia (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.